Nippon Life Global Investors Americas’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,780
Closed -$6.41M 108
2024
Q3
$6.41M Buy
+15,780
New +$5.78M 0.28% 67
2024
Q1
Sell
-5,050
Closed -$1.37M 122
2023
Q4
$1.37M Buy
5,050
+1,470
+41% +$363K 0.08% 102
2023
Q3
$881K Sell
3,580
-8,880
-71% -$2.43M 0.05% 115
2023
Q2
$3.78M Sell
12,460
-19,660
-61% -$5.47M 0.26% 66
2023
Q1
$8.47M Hold
32,120
0.54% 54
2022
Q4
$7.71M Sell
32,120
-5,210
-14% -$1.17M 0.51% 57
2022
Q3
$6.86M Sell
37,330
-960
-3% -$191K 0.48% 57
2022
Q2
$6.43M Buy
38,290
+9,910
+35% +$2.13M 0.42% 72
2022
Q1
$7.11M Buy
28,380
+880
+3% +$221K 0.38% 74
2021
Q4
$7.07M Buy
+27,500
New +$6.73M 0.33% 84
2020
Q4
Sell
-21,810
Closed -$2.72M 150
2020
Q3
$2.72M Sell
21,810
-5,800
-21% -$718K 0.18% 110
2020
Q2
$2.68M Buy
+27,610
New +$2.87M 0.19% 106

Other funds holding HCA

Nippon Life Global Investors Americas's HCA Position: Q4 2024 in Review

Nippon Life Global Investors Americas sold out of HCA Healthcare (HCA) in Q4 2024, closing a stake of 15,780 shares — an estimated $6.41M sold.

Nippon Life Global Investors Americas first reported a position in HCA in Q2 2020 and held it in 12 quarters. The position peaked at $8.47M in Q1 2023. 1,181 funds tracked by Wall St. Rank hold HCA as of Q4 2024.

  • Nippon Life Global Investors Americas reported no remaining HCA Healthcare position as of Q4 2024 after selling out during the quarter.
  • Nippon Life Global Investors Americas sold 15,780 HCA Healthcare shares in Q4 2024, an estimated $6.41M.
  • Nippon Life Global Investors Americas first reported a position in HCA Healthcare in Q2 2020 and held it in 12 quarters.
  • Nippon Life Global Investors Americas's HCA Healthcare position peaked at $8.47M in Q1 2023.
  • 1,181 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2024.

Based on Nippon Life Global Investors Americas's 13F filing for Q4 2024, filed 14 Feb 2025.